SGS acquires a majority stake in Nutrasource Pharmaceutical, Nutraceutical Services Inc. and its subsidiaries
Counsel to SGS
ZYUS Life Sciences Successfully Completes Brokered Subscription Receipt Financing and Reverse Takeover
Counsel to Stifel GMP
Numinus completes acquisition of Novamind
Counsel to Numinus Wellness Inc.
Sandoz Canada sells sterile injectable medicine manufacturing plant to Delpharm
Canadian counsel to Sandoz Canada Inc.
MYND Life Sciences closes fully subscribed $3 million non-brokered private placement
Counsel to MYND Life Sciences Inc.
Levitee Labs enters into credit facility for up to $12 million
Counsel to RiverFort Global Opportunities PCC Ltd.
Mydecine closes spin-out of U.S. cannabis assets
Counsel to Mydecine Innovations Group
Numinus, a pioneer in the psychedelic-assisted integrative health industry, closes $40 million bought deal financing
Counsel to Numinus Wellness Inc.
Mydecine Innovations Group closes $17.25 million bought deal public offering
Counsel to Mydecine Innovations Group
